# NAYA Biosciences Inc. (NAYA) Source: https://www.quantisnow.com/company/NAYA Generated: 2026-11-12T22:23:36.955Z - Ticker: NAYA - Exchange: NASDAQ - Sector: Health Care - Industry: Medical/Dental Instruments ## Latest NAYA news and filings - 2025-04-30 19:43 UTC [SEC Form 8-K] [NAYA Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities](https://www.quantisnow.com/insight/naya-biosciences-inc-filed-sec-form-8-k-entry-into-a-6010002) - 2025-04-30 13:00 UTC [SEC Form 8-K] [NAYA Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/naya-biosciences-inc-filed-sec-form-8-k-results-of-operations-6009287) - 2025-04-30 00:43 UTC [SEC Form 10-K] [SEC Form 10-K filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-naya-biosciences-inc-6008496) - 2025-04-24 13:00 UTC [INVO Fertility Confirms New Nasdaq Trading Symbol of "IVF"](https://www.quantisnow.com/insight/invo-fertility-confirms-new-nasdaq-trading-symbol-of-ivf-5999883) - 2025-04-18 17:14 UTC [SEC Form 8-K] [NAYA Biosciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/naya-biosciences-inc-filed-sec-form-8-k-notice-of-delisting-5993412) - 2025-04-14 23:30 UTC [NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed "INVO Fertility, Inc."](https://www.quantisnow.com/insight/naya-biosciences-announces-strategic-decision-to-separate-fertility-and-oncology-5987389) - 2025-04-14 13:00 UTC [SEC Form 8-K] [NAYA Biosciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/naya-biosciences-inc-filed-sec-form-8-k-submission-of-matters-5986444) - 2025-03-31 21:23 UTC [SEC Form NT 10-K filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-naya-biosciences-inc-5967814) - 2025-03-31 20:49 UTC [SEC Form 8-K] [NAYA Biosciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/naya-biosciences-inc-filed-sec-form-8-k-notice-of-delisting-5967550) - 2025-03-24 20:49 UTC [SEC Form 8-K] [NAYA Biosciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/naya-biosciences-inc-filed-sec-form-8-k-amendments-to-articles-5957965) - 2025-03-13 20:30 UTC [NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025](https://www.quantisnow.com/insight/naya-announces-a-112-reverse-stock-split-effective-pre-market-opening-5943482) - 2025-03-12 20:05 UTC [SEC Form DEFR14A filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-defr14a-filed-by-naya-biosciences-inc-5940692) - 2025-03-07 21:05 UTC [SEC Form 8-K] [NAYA Biosciences Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/naya-biosciences-inc-filed-sec-form-8-k-other-events-5933287) - 2025-02-25 21:38 UTC [SEC Form S-8] [SEC Form S-8 filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-naya-biosciences-inc-5908744) - 2025-02-25 13:00 UTC [NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment](https://www.quantisnow.com/insight/naya-biosciences-supports-recent-executive-order-aimed-at-improving-access-5907144) - 2025-02-19 14:15 UTC [NAYA Biosciences Announces Nomination of New Board Members](https://www.quantisnow.com/insight/naya-biosciences-announces-nomination-of-new-board-members-5896032) - 2025-02-13 18:53 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-naya-biosciences-inc-5887023) - 2025-02-11 19:58 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-naya-biosciences-inc-5881702) - 2025-01-31 21:19 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-naya-biosciences-inc-5865351) - 2025-01-16 20:00 UTC [SEC Form 8-K] [NAYA Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Events That Accelerate or Increase a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/naya-biosciences-inc-filed-sec-form-8-k-entry-into-a-5848319) - 2025-01-14 18:25 UTC [SEC Form 424B4 filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-naya-biosciences-inc-5845315) - 2025-01-14 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-naya-biosciences-inc-5844668) - 2025-01-13 14:15 UTC [Public Offering] [NAYA Biosciences Announces Pricing of $9.5 Million Public Offering](https://www.quantisnow.com/insight/naya-biosciences-announces-pricing-of-95-million-public-offering-5843631) - 2025-01-08 22:10 UTC [SEC Form S-1] [Amendment: SEC Form S-1/A filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-1a-filed-by-naya-biosciences-inc-5840014) - 2025-01-07 22:10 UTC [SEC Form 8-K] [NAYA Biosciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/naya-biosciences-inc-filed-sec-form-8-k-other-events-financial-5838031) - 2025-01-07 13:18 UTC [SEC Form S-1] [Amendment: SEC Form S-1/A filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-1a-filed-by-naya-biosciences-inc-5836902) - 2025-01-06 13:30 UTC [NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody](https://www.quantisnow.com/insight/naya-biosciences-announces-development-of-ny-500-a-novel-ai-optimized-pd-1-5833880) - 2024-12-23 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-naya-biosciences-inc-5822978) - 2024-12-17 20:53 UTC [SEC Form S-1] [SEC Form S-1 filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-naya-biosciences-inc-5816620) - 2024-12-13 22:30 UTC [SEC Form S-3] [Amendment: SEC Form S-3/A filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-3a-filed-by-naya-biosciences-inc-5813537) - 2024-12-12 21:47 UTC [SEC Form 8-K] [Amendment: NAYA Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-naya-biosciences-inc-filed-sec-form-8-k-entry-into-5811569) - 2024-11-19 21:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-naya-biosciences-inc-5782877) - 2024-11-19 21:10 UTC [SEC Form 10-Q] [Amendment: SEC Form 10-Q/A filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-qa-filed-by-naya-biosciences-inc-5782787) - 2024-11-19 21:05 UTC [SEC Form 10-K] [Amendment: SEC Form 10-K/A filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-ka-filed-by-naya-biosciences-inc-5782692) - 2024-11-14 21:54 UTC [SEC Form NT 10-Q filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-naya-biosciences-inc-5776795) - 2024-11-13 16:18 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by NAYA Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-naya-biosciences-inc-5770637) - 2024-11-08 21:14 UTC [SEC Form 8-K] [NAYA Biosciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/naya-biosciences-inc-filed-sec-form-8-k-other-events-financial-5762655) - 2024-10-31 13:00 UTC [NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)](https://www.quantisnow.com/insight/naya-biosciences-to-present-translational-insights-to-support-phase-iiia-5745715) - 2024-10-24 13:00 UTC [NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma](https://www.quantisnow.com/insight/naya-biosciences-announces-initiation-of-phase-12a-clinical-trial-for-5736533) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/NAYA - Earnings history: https://www.quantisnow.com/earnings/NAYA - Dividend history: https://www.quantisnow.com/dividends/NAYA - Insider transactions: https://www.quantisnow.com/insiders/NAYA - Options chain: https://www.quantisnow.com/options/NAYA - SEC 8-K filings only: https://www.quantisnow.com/company/NAYA/8-k - RSS and alerts for NAYA: https://www.quantisnow.com/docs/rss-feeds.md